Covagen
BelgiumWho owns Covagen?
Covagen is a Belgian Biotech company, now owned by Cilag GmbH International, which acquired it in 2014 from Andera Partners and Gimv.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods
Andera Partners sold Covagen to Johnson & Johnson in 2014 after 4 years.
Gimv sold Covagen to Cilag GmbH International in 2014.
More from BioDiscovery 3
Other portfolio companies in the same fund.
France
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Covagen?
Covagen is now owned by Cilag GmbH International, which acquired it in 2014 from Andera Partners and Gimv.
When did Cilag GmbH International acquire Covagen?
Cilag GmbH International acquired Covagen in 2014, buying from Andera Partners and Gimv.
Who did Covagen sell to?
Andera Partners sold Covagen to Johnson & Johnson in 2014 (Trade Sale). Gimv sold Covagen to Cilag GmbH International in 2014 (Trade Sale).
Who has owned Covagen over time?
Covagen has been through 2 private-equity ownership periods: Andera Partners · via BioDiscovery 3 · 2010–2014 · sold to Johnson & Johnson · (Trade Sale); Gimv · sold to Cilag GmbH International · (Trade Sale).